Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.17
+0.00500.43%
Volume:925.75K
Turnover:1.08M
Market Cap:179.66M
PE:-1.16
High:1.19
Open:1.19
Low:1.15
Close:1.16
52wk High:2.62
52wk Low:1.09
Shares:154.22M
Float Shares:136.00M
Volume Ratio:0.93
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0011
EPS(LYR):1.43
ROE:-178.39%
ROA:-30.52%
PB:2.95
PE(LYR):0.81

Loading ...

Coherus Oncology (CHRS) Q1 Loss Of US$36.9 Million Tests Bullish Growth Narratives

Simply Wall St.
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (CHRS), Moderna (MRNA) and Skye Bioscience (SKYE)

TIPRANKS
·
May 12

Coherus Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Coherus Oncology Q1 Sales USD 12.31 Million Vs. IBES Estimate USD 14.3 Million

Reuters
·
May 12

Coherus Oncology Q1 sales rise

Reuters
·
May 12

Coherus BioSciences Q1 Adj. EPS $(0.25) Beats $(0.27) Estimate, Sales $12.310M Miss $14.342M Estimate

Benzinga Earnings
·
May 12

Coherus Q1 FY26 operating loss narrows to $36.15 million; revenue rises to $12.31 million

Reuters
·
May 12

Coherus Oncology Q1 Sales USD 12.31 Million VS. Ibes Estimate USD 14.3 Million

THOMSON REUTERS
·
May 12

Coherus Oncology Q1 EPS USD -0.28

THOMSON REUTERS
·
May 12

Coherus Oncology Q1 Adjusted Net Income USD -33.925 Million

THOMSON REUTERS
·
May 12

Coherus Oncology Initiated at Buy by Guggenheim

Dow Jones
·
May 12

Guggenheim starts Coherus with Buy on anti-tumor potential

TIPRANKS
·
May 11

Coherus Oncology Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $12

THOMSON REUTERS
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Coherus Oncology Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Coherus Oncology schedules first-quarter 2026 results conference call

Reuters
·
May 04

NervGen Pharma appoints Keith Vendola as CFO

Reuters
·
Apr 27

Coherus Oncology announces annual shareholder meeting

Reuters
·
Apr 10

Coherus BioSciences Charts Leaner Path After Earnings Call

TIPRANKS
·
Apr 03